We further proved that the expression of A20 was strongly correlated with IL-17 expression in CD4+T cells from active BD patients, and silencing of A20 could shift CD4+T cells toward a Th1 and Th17 phenotype. The gene discussed is CD4; the disease is Behcet disease.